|
国际皮肤性病学杂志 2004 30 (5): 282-284 ISSN: 2096-5540 CN: 32-1880/R |
|
|
|
|
|
甲真菌病的联合治疗 |
陶诗沁1, 刘维达2 |
1. 无锡市第二人民医院皮肤科 214000; 2. 中国医学科学院、中国协和医科大学皮肤病研究所 |
收稿日期 2003-12-16 修回日期 null 网络版发布日期 null |
参考文献 [1] Roberts DT,Taylor WD,Boyle J,et al.Guidelines for treatment of onychomycosis.Br J Dermatol,2003,148:402-410. [2] Evans EG,Sigurgeirsson B.Double blind,randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis.The LION Study Group.BMJ,1999,318:1031-1035. [3] Gupta AK,De Doncker P,Scher RK,et al.Itraconazole for the treatment of onychomycosis.Int J Dermatol,1998,37:303-308. [4] Epstein E.How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.Arch Dermatol,1998,134:1551-1554. [5] Sigurgeirsson B,Olafsson JH,Steinsson JB,et al.Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis:a 5-year blinded prospective follow-up study.Arch Dermatol,2002,138:353-357. [6] Soher RK,Baran R.Onychomycosis in clinical practice:factors contributing to recurrence.Br J Dermatol,2003,149:5-9. [7] Faergemann J,Baran R.Epidemiology,clinical presentation and diagnosis of onychomycosis.Br J Dermatol,2003,149:1-4. [8] Hay RJ.The future of onychomycosis therapy may involve a combination of approaches.Br J Dermatol,2001,145:3-8. [9] Olafsson JH,Sigurgeirsson B,Baran R.Combination therapy for onychomycosis.Br J Dermatol,2003,149:15-18. [10] Evans EG.Drug synergies and the potential for combination therapy in onychomycosis.Br J Dermatol,2003,149:1 1-13. [11] Arenas R,Fernandez G,Dominguez L.Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent.Int J Dermatol,1991,30:586-589. [12] Hay RJ,Clayton YM,Moore MK.A comparison of tioconazole 28%nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis.Clin Exp Dermatol,1987,12(3):175-177. [13] Baran R.Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine,a cost-effective treatment for onychomycosis.Br J Dermatol,2001,145:15-19. [14] Lecha M.Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.Br J Dermatol,2001,145:21-26. [15] Lambert J.Pharmacoeconomic issues in onychomycosis.Br J Dermatol,2003,149:19-22. [16] Baran R,Feuilhade M,Combernale P,et al.A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.Br J Dermatol,2000,142:1177-1183. |
|
|
|
通讯作者: |
|